BCG和α-干扰素联合灌注预防膀胱癌术后复发的疗效分析
被引量:1
摘要
我院自1991年起应用BCG与α-干扰素联合膀胱内灌注预防膀胱癌术后复发,取得较好疗效.现报告如下.1
出处
《医学理论与实践》
2001年第7期591-591,共1页
The Journal of Medical Theory and Practice
同被引文献41
-
1杨士保,孙振球.Meta分析.方积乾,主编.卫生统计学.第5版.北京:人民卫生出版社,2003.399-416.
-
2Reijke TM,Kurth KH,Sylvester RJ,et al.Bacillus Calmette-Guerin versus epirubicin for primary,secondary or concurrent carcinoma in situ of the bladder:results of a European Organization for the Research and Treatment of Cancer-Genito-Urinary Group Phase Ⅲ Trial.J Urol,2005,173:405-409.
-
3Di Stasi SM,Giannantoni A,Stephen RL,et al.Intravesical electromotive mitomycin C versus passive transport mitomycin C for high risk superficial bladder cancer:a prospective randomized study.J Urol,2003,170:777-782.
-
4Kaasinen E,Wijkstrom H,Malmstrom PU,et al.Alternating mitomycin C and BCG instillations versus BCG alone in treatment of carcinoma in situ of the urinary bladder:a nordic study.Eur Urol,2003,43:637-645.
-
5Tozawa K,Okamura T,Sasaki S,et al.Intravesical combined chemoimmunotherapy with epirubicin and bacillus Calmette-Guerin is not indicated for superficial bladder cancer.Urol Int,2001,67:289-292.
-
6Sekine H,Ohya K,Kojima SI,et al.Equivalent efficacy of mitomycin C plus doxorubicin instillation to bacillus Calmette-Guerin therapy for carcinoma in situ of the bladder.Int J Urol,2001,8:483-486.
-
7Takashi M,Shimoji T,Murase T,et al.Intravesical bacillus Calmette-Guerin (Tokyo 172 strain) therapy for carcinoma in situ of the bladder.Int Urol Nephrol,1997,29:557-563.
-
8Melekos MD,Zarakovitis I,Dandinis K,et al.BCG versus epirubicin in the prophylaxis of multiple superficial bladder tumours:results of a prospective randomized study using modified treatment schemes.Int Urol Nephrol,1996,28:499-509.
-
9Rintala E,Jauhiainen K,Rajala P,et al.Alternating mitomycin C and bacillus Calmette-Guerin instillation therapy for carcinoma in situ of the bladder.The Finnbladder Group.J Urol,1995,154:2050-2053.
-
10Bercovich E,Deriu M,Manferrari F,et al.BCG vs.BCG plus recombinant alpha-interferon 2b in superficial tumors of the bladder.Arch Ital Urol Androl,1995,67:257-260.
二级引证文献2
-
1黄金杯,薛学义,郑清水,许宁,魏勇,李晓东,叶敏.丝裂霉素C与羟基喜树碱对膀胱癌术后化疗的有效性及安全性比较的Meta分析[J].中国生化药物杂志,2014,34(6):74-77. 被引量:3
-
2许明伟,张杰,周晓光,王伟,程凯.表浅性膀胱癌患者的循证治疗[J].医学综述,2012,18(10):1587-1590.
-
1章振保,杨镜秋,郑俊鸿.经尿道膀胱肿瘤电切术联合灌注丝裂霉素C治疗膀胱癌29例[J].汕头大学医学院学报,2004,17(4):206-206. 被引量:3
-
2许海波,张祖洪,肖劲逐,欧善际,颜毅.丝裂霉素、卡介苗联合灌注预防膀胱癌术后复发[J].海南医学,2002,13(6):11-12.
-
3李增云,马庆彤,崔言刚,邵书元,陈述泉,王达.白介素-2联合顺铂治疗恶性心包积液的疗效观察[J].现代肿瘤医学,2006,14(6):699-700. 被引量:9
-
4张娟,孙秋实,张凌云.重组改构人肿瘤坏死因子联合博来霉素胸腔灌注治疗肺癌恶性胸腔积液的临床观察[J].临床肿瘤学杂志,2011,16(12):1104-1107. 被引量:16
-
5黄诚,毛雪华,庄武,杨建伟,杨瑜,林小燕.支气管动脉大剂量顺铂联合灌注治疗肺癌[J].实用肿瘤学杂志,1991,5(2):58-60.
-
6刘亚贝,李烨,唐艳,陈曼萍,胡冰,林新民,鲁朝晖,范平生.维拉帕米联合化疗药物治疗恶性胸腹水的临床观察[J].安徽医药,2010,14(4):453-455. 被引量:14
-
7王建伟,周丽华,张勇.吉西他滨与α-干扰素联合灌注化疗预防膀胱癌复发的临床研究[J].滨州医学院学报,2014,37(4):275-276. 被引量:3
-
8黄诚,毛雪华,庄武,杨建伟,杨瑜,林小燕.选择性支气管动脉大剂量顺铂联合灌注治疗肺癌[J].福建医学院学报,1991,25(3):233-235.
-
9王斌,崔书钟,唐云强,王嘉康,张相良,赵宏宇,王来奎.羟基喜树碱与白介素——2膀胱灌注预防膀胱癌复发的临床研究[J].国际医药卫生导报,2006,12(20):40-41. 被引量:2
-
10杨雪,朱凤飞,程晓健,寇克韧.甘露聚糖肽联合灌注顺铂治疗恶性胸腹腔积液临床效果分析[J].医药前沿,2017,7(6):82-84.